4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯(917392-54-2)名称与标识符
名称
中文别名:
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸甲酯;4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯;
英文别名:
Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester;Benzoicacid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, methyl ester;METHYL 4-METHYL-3-(4-(PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)BENZOATE;methyl 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoate;Everolimus;Methyl 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate;917392-54-2;DB-079163;Methyl4-Methyl-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzoate;UNII-HKX2YWY42Y;CS-0321831;NS00008500;Methyl 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic Acid Ester; Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, methyl ester; Methyl 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate; Methyl 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate; Nilotinib methyl ester;AKOS015917907;NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY G [EP IMPURITY];METHYL 4-METHYL-3-{[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}BENZOATE;BECBKQYLJDEVDN-UHFFFAOYSA-N;4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzoic acid methyl ester;HKX2YWY42Y;SCHEMBL534524;DTXSID40589940;EC 700-542-4;MFCD16619370;
标识符
InChIKey:
BECBKQYLJDEVDN-UHFFFAOYSA-N
Inchi:
1S/C18H16N4O2/c1-12-5-6-13(17(23)24-2)10-16(12)22-18-20-9-7-15(21-18)14-4-3-8-19-11-14/h3-11H,1-2H3,(H,20,21,22)
SMILES:
O=C(C1C=C(NC2N=C(C3C=CC=NC=3)C=CN=2)C(C)=CC=1)OC